139 related articles for article (PubMed ID: 16368533)
21. Cross Talk Between Cellular Redox State and the Antiapoptotic Protein Bcl-2.
Pohl SÖ; Agostino M; Dharmarajan A; Pervaiz S
Antioxid Redox Signal; 2018 Nov; 29(13):1215-1236. PubMed ID: 29304561
[TBL] [Abstract][Full Text] [Related]
22. The Bcl2 family: regulators of the cellular life-or-death switch.
Cory S; Adams JM
Nat Rev Cancer; 2002 Sep; 2(9):647-56. PubMed ID: 12209154
[TBL] [Abstract][Full Text] [Related]
23. Selective induction of apoptosis by the pyrrolo-1,5-benzoxazepine 7-[[dimethylcarbamoyl]oxy]-6-(2-naphthyl)pyrrolo-[2,1-d] (1,5)-benzoxazepine (PBOX-6) in Leukemia cells occurs via the c-Jun NH2-terminal kinase-dependent phosphorylation and inactivation of Bcl-2 and Bcl-XL.
Mc Gee MM; Greene LM; Ledwidge S; Campiani G; Nacci V; Lawler M; Williams DC; Zisterer DM
J Pharmacol Exp Ther; 2004 Sep; 310(3):1084-95. PubMed ID: 15143129
[TBL] [Abstract][Full Text] [Related]
24. The Siva-1 putative amphipathic helical region (SAH) is sufficient to bind to BCL-XL and sensitize cells to UV radiation induced apoptosis.
Chu F; Borthakur A; Sun X; Barkinge J; Gudi R; Hawkins S; Prasad KV
Apoptosis; 2004 Jan; 9(1):83-95. PubMed ID: 14739602
[TBL] [Abstract][Full Text] [Related]
25. Evidence for involvement of BH3-only proapoptotic members in adenovirus-induced apoptosis.
Subramanian T; Vijayalingam S; Lomonosova E; Zhao LJ; Chinnadurai G
J Virol; 2007 Oct; 81(19):10486-95. PubMed ID: 17652400
[TBL] [Abstract][Full Text] [Related]
26. A functional role for nicotine in Bcl2 phosphorylation and suppression of apoptosis.
Mai H; May WS; Gao F; Jin Z; Deng X
J Biol Chem; 2003 Jan; 278(3):1886-91. PubMed ID: 12421819
[TBL] [Abstract][Full Text] [Related]
27. Synchronised phosphorylation of BNIP3, Bcl-2 and Bcl-xL in response to microtubule-active drugs is JNK-independent and requires a mitotic kinase.
Mellor HR; Rouschop KM; Wigfield SM; Wouters BG; Harris AL
Biochem Pharmacol; 2010 Jun; 79(11):1562-72. PubMed ID: 20100468
[TBL] [Abstract][Full Text] [Related]
28. Reprogramming cell death: BCL2 family inhibition in hematological malignancies.
Scarfò L; Ghia P
Immunol Lett; 2013; 155(1-2):36-9. PubMed ID: 24095849
[TBL] [Abstract][Full Text] [Related]
29. BAX and BAK1 are dispensable for ABT-737-induced dissociation of the BCL2-BECN1 complex and autophagy.
Pedro JM; Wei Y; Sica V; Maiuri MC; Zou Z; Kroemer G; Levine B
Autophagy; 2015; 11(3):452-9. PubMed ID: 25715028
[TBL] [Abstract][Full Text] [Related]
30. Bcl-2 family proteins: the sentinels of the mitochondrial apoptosis pathway.
Wong WW; Puthalakath H
IUBMB Life; 2008 Jun; 60(6):390-7. PubMed ID: 18425793
[TBL] [Abstract][Full Text] [Related]
31. JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis.
Lei K; Davis RJ
Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2432-7. PubMed ID: 12591950
[TBL] [Abstract][Full Text] [Related]
32. Importance of the Bcl-2 family in cell death regulation.
McDonnell TJ; Beham A; Sarkiss M; Andersen MM; Lo P
Experientia; 1996 Oct; 52(10-11):1008-17. PubMed ID: 8917732
[TBL] [Abstract][Full Text] [Related]
33. N-terminal truncation of antiapoptotic MCL1, but not G2/M-induced phosphorylation, is associated with stabilization and abundant expression in tumor cells.
De Biasio A; Vrana JA; Zhou P; Qian L; Bieszczad CK; Braley KE; Domina AM; Weintraub SJ; Neveu JM; Lane WS; Craig RW
J Biol Chem; 2007 Aug; 282(33):23919-36. PubMed ID: 17561513
[TBL] [Abstract][Full Text] [Related]
34. Expression and function of a proapoptotic Bcl-2 family member Bcl-XL/Bcl-2-associated death promoter (BAD) in rat ovary.
Kaipia A; Hsu SY; Hsueh AJ
Endocrinology; 1997 Dec; 138(12):5497-504. PubMed ID: 9389536
[TBL] [Abstract][Full Text] [Related]
35. BAD/BCL-[X(L)] heterodimerization leads to bypass of G0/G1 arrest.
Chattopadhyay A; Chiang CW; Yang E
Oncogene; 2001 Jul; 20(33):4507-18. PubMed ID: 11494146
[TBL] [Abstract][Full Text] [Related]
36. Expression of pro- and antiapoptotic molecules of the Bcl-2 family in human islets postisolation.
Campbell PD; Weinberg A; Chee J; Mariana L; Ayala R; Hawthorne WJ; O'Connell PJ; Loudovaris T; Cowley MJ; Kay TW; Grey ST; Thomas HE
Cell Transplant; 2012; 21(1):49-60. PubMed ID: 21535910
[TBL] [Abstract][Full Text] [Related]
37. Molecular targeting of BCL2 and BCLXL proteins by synthetic BCL2 homology 3 domain peptide enhances the efficacy of chemotherapy.
Dharap SS; Chandna P; Wang Y; Khandare JJ; Qiu B; Stein S; Minko T
J Pharmacol Exp Ther; 2006 Mar; 316(3):992-8. PubMed ID: 16291730
[TBL] [Abstract][Full Text] [Related]
38. The Bcl-xL inhibitor, ABT-737, efficiently induces apoptosis and suppresses growth of hepatoma cells in combination with sorafenib.
Hikita H; Takehara T; Shimizu S; Kodama T; Shigekawa M; Iwase K; Hosui A; Miyagi T; Tatsumi T; Ishida H; Li W; Kanto T; Hiramatsu N; Hayashi N
Hepatology; 2010 Oct; 52(4):1310-21. PubMed ID: 20799354
[TBL] [Abstract][Full Text] [Related]
39. Lemur tyrosine kinase 2 (LMTK2) is a determinant of cell sensitivity to apoptosis by regulating the levels of the BCL2 family members.
Conti A; Majorini MT; Fontanella E; Bardelli A; Giacca M; Delia D; Mano M; Lecis D
Cancer Lett; 2017 Mar; 389():59-69. PubMed ID: 28040547
[TBL] [Abstract][Full Text] [Related]
40. Characterization of vinblastine-induced Bcl-xL and Bcl-2 phosphorylation: evidence for a novel protein kinase and a coordinated phosphorylation/dephosphorylation cycle associated with apoptosis induction.
Du L; Lyle CS; Chambers TC
Oncogene; 2005 Jan; 24(1):107-17. PubMed ID: 15531923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
